Oftalmo MD
The computed 12-month bankruptcy probability of Oftalmo MD is 0.3% (very low). The company has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 14 yrs |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2021 | verkort | 20-03-2022 | 2022-08100440 |
| 31-12-2020 | verkort | 27-07-2021 | 2021-40500111 |
| 31-12-2019 | verkort | 30-10-2020 | 2020-66500207 |
| 31-12-2018 | verkort | 22-07-2019 | 2019-36300049 |
| 31-12-2017 | verkort | 24-07-2018 | 2018-37100462 |
| 31-12-2016 | verkort | 17-07-2017 | 2017-34300485 |
| 31-12-2015 | verkort | 21-07-2016 | 2016-34600541 |
| 31-12-2014 | verkort | 15-07-2015 | 2015-31400404 |
| 31-12-2013 | verkort | 23-07-2014 | 2014-33700037 |
| 31-12-2012 | verkort | 25-07-2013 | 2013-35100552 |
| NACE primary | - |
| Legal form | General partnership(011) |
| Incorporation | 19-12-2011 |
| Status | Active |
| Postal code | 2270 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13012E0407/00H000 | Flanders | 1,124 m² | 1 · 140 m² | 12.4 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
23-12-2022 Share split
Technical details
{
"events": [
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": 10000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frank Liesse",
"firm_city": null,
"firm_name": "Celis \u0026 Liesse, geassocieerde notarissen",
"office_city": "Antwerpen",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-23",
"filing_date": "2022-12-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-12",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": "0809.489.744",
"firm_name": "DE DEYNE, VERHOEYE ACCOUNTANTS EN BELASTINGCONSULENTEN BV",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Yves Willemot"
},
"subject_company": {
"kbo": "0842.018.396",
"name_full": "Oftalmo MD",
"legal_form": "Besloten vennootschap met beperkte aansprakelijkheid",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"afschrift akte",
"nieuwe statuten",
"staat van activa en passiva per 31 oktober 2022",
"verslag bestuursorgaan cfr. art. 14:5 WVV",
"verslag bedrijfsrevisor cfr. art. 14:4 WVV"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "DIELTI\u00CBNS Maria Anna",
"role": "g\u00E9rant_statutaire",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "TANGHE Luc Jeanne Joseph",
"role": "g\u00E9rant_statutaire",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Oftalmo MD |